ABVX — Abivax SA Income Statement
0.000.00%
Last trade - 00:00
- €867.00m
- €661.34m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | -0.016 | -0.001 | — | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 33.2 | 37.8 | 42.4 | 70.5 | 127 |
Operating Profit | -33.2 | -37.8 | -42.4 | -70.5 | -127 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -34.9 | -40.1 | -45.6 | -74.3 | -148 |
Provision for Income Taxes | |||||
Net Income After Taxes | -30.6 | -37.6 | -41.4 | -69.8 | -148 |
Net Income Before Extraordinary Items | |||||
Net Income | -30.6 | -37.6 | -41.4 | -69.8 | -148 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -30.6 | -37.6 | -41.4 | -69.8 | -148 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.52 | -2.63 | -2.47 | -2.73 | -3.43 |
Dividends per Share |